Prophylactic use of myelopoietic growth factors in children after myelosuppressive chemotherapy: does it pay?

J Pediatr Hematol Oncol. 2003 Jun;25(6):435-40. doi: 10.1097/00043426-200306000-00003.
No abstract available

Publication types

  • Comparative Study
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / economics
  • Antineoplastic Agents / therapeutic use*
  • Child
  • Cost-Benefit Analysis
  • Economics, Pharmaceutical
  • Granulocyte Colony-Stimulating Factor / economics
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Leukemia / drug therapy
  • Leukemia / economics
  • Leukemia / therapy*
  • Neutropenia / chemically induced
  • Neutropenia / prevention & control*

Substances

  • Antineoplastic Agents
  • Granulocyte Colony-Stimulating Factor